Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy IV: Restrictive Cardiomyopathy

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...

Cardiomyopathy VI: Nursing Management

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Physiological characterization of pressure-strain loops indices as non-invasive surrogates for ventriculo-arterial coupling: a proof-of-concept study.

Scientific reports·2026

Same author

Using Markov chains and temporal alignment to identify clinical patterns in Dementia.

Journal of biomedical informatics·2023

Same author

An isothermal lab-on-phone test for easy molecular diagnosis of SARS-CoV-2 near patients and in less than 1 hour.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2022

Same author

Therapeutic Plasmapheresis: Seven Year Experience of an Intensive Care Unit in Portugal.

Acta medica portuguesa·2021

Same author

IL-6 and TNF-α salivary levels according to the periodontal status in Portuguese pregnant women.

PeerJ·2018

Same author

Overactive Bladder Symptoms after Transobturator Sling Surgery for Pure Stress Urinary Incontinence: A Cross-Sectional Comparative Study.

Urologia internationalis·2018

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[Peripartum cardiomyopathy].

Catarina Gama Pinto¹, João Colaço, Miguel Maya

¹Serviço de Obstetrícia, Hospital Garcia de Orta, Almada.

Acta Medica Portuguesa

|February 20, 2008

Summary

Peripartum cardiomyopathy (PPCM) is a rare heart condition affecting women late in pregnancy or postpartum. This case highlights PPCM in a nulliparous woman with a favorable prognosis and full recovery.

Area of Science:

Cardiology
Obstetrics
Maternal-Fetal Medicine

Background:

Peripartum cardiomyopathy (PPCM) is a rare heart condition of uncertain etiology.
It typically affects multiparous women over thirty, presenting as congestive heart failure near delivery or postpartum.
Diagnosis involves radiography, ECG, and echocardiography, with treatment focusing on medical management and, in severe cases, cardiac transplantation.

Observation:

This report details a case of PPCM in a 33-year-old, nulliparous Black woman with no prior heart disease.
The patient developed sudden heart failure with ventricular dysfunction post-cesarean delivery.
Echocardiography confirmed left ventricular systolic dysfunction.

Findings:

The patient experienced a full recovery of normal ventricular function by the 11th day of the puerperium.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An Intact Pericardium Ischemic Rodent Model

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

Related Experiment Videos

Last Updated: Jul 7, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

An Intact Pericardium Ischemic Rodent Model

An Intact Pericardium Ischemic Rodent Model

Published on: September 2, 2021

This contrasts with typical PPCM presentations and suggests a potentially better prognosis in some cases.

The case underscores the importance of considering PPCM even in atypical patient demographics.

Implications:

This case expands the understanding of PPCM presentation and recovery patterns.
It suggests that factors beyond parity and age may influence PPCM development and prognosis.
Further research into risk factors and early detection is warranted for improved maternal outcomes.